ABEONA THERAPEUTICS INC. short interest in 2026
In 2026, ABEONA THERAPEUTICS INC.'s disclosed short interest ran from 25.50% of shares outstanding on 15 Jan 2026 to 27.53% on 15 Sep 2026, a change of +2.03 percentage points. The year's high was 28.90% on 30 Apr 2026 and its low 23.20% on 15 Jul 2026, averaging 25.81% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 22.53 days on 30 Apr 2026. Full history: ABEONA THERAPEUTICS INC..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 25.50% (15 Jan 2026)
- End of year
- 27.53% (15 Sep 2026)
- Change
- +2.03 pp
- High
- 28.90% (30 Apr 2026)
- Low
- 23.20% (15 Jul 2026)
- Average
- 25.81%
- Highest days to cover
- 22.53 (30 Apr 2026)
- SEC filings marked
- 6
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 25.50% | 11.76 | |
| 30 Jan 2026 | 26.45% | 10.36 | |
| 13 Feb 2026 | 25.26% | 14.31 | |
| 27 Feb 2026 | 24.08% | 15.22 | |
| 13 Mar 2026 | 26.47% | 11.76 | |
| 31 Mar 2026 | 27.77% | 9.60 | 10-K filed, results (8-K) |
| 15 Apr 2026 | 28.87% | 13.53 | |
| 30 Apr 2026 | 28.90% | 22.53 | |
| 15 May 2026 | 25.36% | 10.22 | 10-Q filed, results (8-K) |
| 29 May 2026 | 25.23% | 16.41 | |
| 15 Jun 2026 | 24.78% | 16.43 | |
| 30 Jun 2026 | 23.98% | 8.67 | |
| 15 Jul 2026 | 23.20% | 8.28 | |
| 31 Jul 2026 | 23.91% | 12.89 | |
| 14 Aug 2026 | 24.96% | 6.87 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 26.51% | 13.93 | |
| 15 Sep 2026 | 27.53% | 11.99 |
See also: ABEONA THERAPEUTICS INC.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.